These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer. Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297 [TBL] [Abstract][Full Text] [Related]
24. Skp2 and Slug Are Coexpressed in Aggressive Prostate Cancer and Inhibited by Neddylation Blockade. Mickova A; Kharaishvili G; Kurfurstova D; Gachechiladze M; Kral M; Vacek O; Pokryvkova B; Mistrik M; Soucek K; Bouchal J Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799604 [TBL] [Abstract][Full Text] [Related]
25. On-chip screening for prostate cancer: an EIS microfluidic platform for contemporary detection of free and total PSA. Chiriacò MS; Primiceri E; Montanaro A; de Feo F; Leone L; Rinaldi R; Maruccio G Analyst; 2013 Sep; 138(18):5404-10. PubMed ID: 23884165 [TBL] [Abstract][Full Text] [Related]
26. Comparative study of separation between ex vivo prostatic malignant and benign tissue using electrical impedance spectroscopy and electrical impedance tomography. Murphy EK; Mahara A; Khan S; Hyams ES; Schned AR; Pettus J; Halter RJ Physiol Meas; 2017 Jun; 38(6):1242-1261. PubMed ID: 28282026 [TBL] [Abstract][Full Text] [Related]
28. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression. Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427 [TBL] [Abstract][Full Text] [Related]
29. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells. Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833 [TBL] [Abstract][Full Text] [Related]
30. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach. Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055 [TBL] [Abstract][Full Text] [Related]
31. Hypoxia stabilizes GAS6/Axl signaling in metastatic prostate cancer. Mishra A; Wang J; Shiozawa Y; McGee S; Kim J; Jung Y; Joseph J; Berry JE; Havens A; Pienta KJ; Taichman RS Mol Cancer Res; 2012 Jun; 10(6):703-12. PubMed ID: 22516347 [TBL] [Abstract][Full Text] [Related]
32. [Expression of "epithelial-mesenchymal transition" associated proteins in prostate cancer cell lines with different metastatic potentials and its significance]. Luo Y; He DL; Ning L Zhonghua Nan Ke Xue; 2006 Aug; 12(8):696-700. PubMed ID: 16970156 [TBL] [Abstract][Full Text] [Related]
33. Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration. Ridge SM; Bhattacharyya D; Dervan E; Naicker SD; Burke AJ; Murphy JM; O'leary K; Greene J; Ryan AE; Sullivan FJ; Glynn SA Int J Cancer; 2018 May; 142(10):2056-2067. PubMed ID: 29266277 [TBL] [Abstract][Full Text] [Related]
34. Phenotypic and genotypic characterization of commonly used human prostatic cell lines. Mitchell S; Abel P; Ware M; Stamp G; Lalani E BJU Int; 2000 May; 85(7):932-44. PubMed ID: 10792179 [TBL] [Abstract][Full Text] [Related]
35. Design and 3D modeling investigation of a microfluidic electrode array for electrical impedance measurement of single yeast cells. Geng Y; Zhu Z; Zhang Z; Xu F; Marchisio MA; Wang Z; Pan D; Zhao X; Huang QA Electrophoresis; 2021 Oct; 42(20):1996-2009. PubMed ID: 33938013 [TBL] [Abstract][Full Text] [Related]
36. Comparison of protein expression in two prostate cancer cell-lines, LNCaP and DU145, after treatment with somatostatin. Liu Z; Marquez M; Nilsson S; Holmberg AR Oncol Rep; 2009 Dec; 22(6):1451-8. PubMed ID: 19885599 [TBL] [Abstract][Full Text] [Related]
37. The transcription factor ZEB1 promotes chemoresistance in prostate cancer cell lines. Orellana-Serradell O; Herrera D; Castellón EA; Contreras HR Asian J Androl; 2019; 21(5):460-467. PubMed ID: 30880686 [TBL] [Abstract][Full Text] [Related]
38. Chemokine receptor expression on integrin-mediated stellate projections of prostate cancer cells in 3D culture. Kiss DL; Windus LC; Avery VM Cytokine; 2013 Oct; 64(1):122-30. PubMed ID: 23921147 [TBL] [Abstract][Full Text] [Related]